Skip to main content

Invivo Therapeutics Holdings Corp.

NVIVDelisted Mar 21, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001292519

Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
14
Q4 2023, −1 vs. previous quarter
13F value
$68.1K
Reported value at the end of Q4 2023
Superinvestors holding
0
At the end of Q4 2023

Superinvestors holding NVIV, Q4 2023

Go to the superinvestors tab

No superinvestor reported holding NVIV at the end of Q4 2023.

Latest insider trades

Open-market purchases and sales by Invivo Therapeutics Holdings Corp. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 7, 2024 (view filing)2:12 PM ETFeb 5-6, 2023367 daysFoose Brice10% OwnerSSaleInVivo Therapeutics Holdings Corp−330.0K$0.3728−$123.0K−100.0%0 afterAmended11 lots

Top 10 13F holders, Q4 2023

The largest institutional positions in Invivo Therapeutics Holdings Corp. at the end of Q4 2023; share changes are against Q3 2023.

See all 14 holders
Institutions holding NVIV in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock Inc.34,714$25.3K0.00%00.0%Unchanged
Vanguard Group Inc31,238$22.8K0.00%+2,300+7.9%Added
Geode Capital Management, LLC18,677$13.6K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)8,395$6.13K0.00%+802+10.6%Added
Morgan Stanley270$1970.00%00.0%Unchanged
Wells Fargo & Company24$180.00%+1+4.3%Added
Advisor Group Holdings, Inc.5$30.00%−1−16.7%Reduced
UBS Group AG1$10.00%−101−99.0%Reduced
Indiana Trust & Investment Management CO2$10.00%00.0%Unchanged
Allworth Financial LP1$10.00%00.0%Unchanged